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Dr Aka
doi:10.1016/j.jtcvs.2007.03.017bjective: Current data suggest that individual genetic predisposition may influence
he magnitude of cytokine response and the degree of organ dysfunction after
ardiopulmonary bypass. Lipoprotein lipase S447X polymorphism has been shown
o be protective against atherosclerosis. The aim of the study was to investigate the
ffect of lipoprotein lipase S447X polymorphism on cytokine release and early
utcome after cardiopulmonary bypass.
ethods: Forty patients who underwent coronary artery bypass grafting with
ardiopulmonary bypass were included. Genotyping for lipoprotein lipase S447X
olymorphism was performed by polymerase chain reaction. Levels of interleukins
and 8 were measured before induction and 6, 24, and 72 hours after operation by
nzyme-linked immunosorbent assay. Clinical data were collected prospectively.
aily assessment of organ dysfunction was done according to the cardiac surgery
coring (CASUS) system.
esults: The allele frequency of lipoprotein lipase S447X stop codon was 17.5%.
447X carriers revealed significantly lower interleukin 8 levels at the sixth and 24th
ostoperative hours than the noncarrier group (P  .005 and P  .041, respec-
ively). Patients in the S447X carrier group had significantly shorter ventilation
imes than the noncarrier group (P  .048). Also, the S447X carrier group revealed
ignificantly lower postoperative 6-hour lactate levels, operative day, and postop-
rative day 1 organ dysfunction scores than the other group (P  .001, .005 and
002, respectively).
onclusion: Lipoprotein lipase S447X stop codon mutation is associated with lower
evels of interleukin 8 after coronary artery bypass grafting. Identification of
igh-risk patients for cardiopulmonary bypass–related systemic inflammation by
etecting lipoprotein lipase S447X stop codon polymorphism may improve early
ostoperative outcome, especially in patients with limited organ reserves.
ardiac surgery with cardiopulmonary bypass (CPB) is associated with a
systemic inflammatory response syndrome (SIRS) that is known to be one
of the main causes of postoperative organ dysfunction.1 Several factors such
s contact of blood with foreign surfaces, surgical trauma, ischemia reperfusion to
he organs, and release of endotoxin have been widely documented to cause SIRS
fter CPB.2 As a consequence of the inflammatory reaction, a clinical pi
anging from a subclinical increase in the humoral inflammatory mediators to
ultiple organ dysfunction with lactic acidosis and even death occurs.2,3 Current
ata suggest that the individual genetic predisposition is an important determinant
f the degree of postoperative SIRS in cardiac surgery. The magnitude of inflam-
atory cytokines, particularly interleukin (IL) 6, IL-8, and tumor necrosis factor–lpha (TNF-) produced during CPB has been shown to be unfavorably altered in
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CDhe presence of IL-6 G174C, apolipoprotein E4, and TNF
A-308 genetic polymorphisms.4-7
Lipoprotein lipase (LPL) is an enzyme that catalyses a
ey step in the removal of triglycerides from the circula-
ion.8 Besides its catalytic activity, data have accumula
hat LPL has a pivotal role in the inflammatory process of
therosclerosis by modulating the cytokine release.9-11 Sev-
ral polymorphisms have been described in the gene coding
or LPL. Of these, LPL S447X stop codon mutation is
egarded as a gain of function mutation and associated with
ncreased peripheral LPL activity and high-density lipopro-
ein, decreased triglycerides, and the decreased risk of cor-
nary artery disease.12,13
We hypothesized that the genotype of the S447X poly-
orphism in the LPL gene may dictate the IL-6 and IL-8
evels and therefore influence the inflammatory response
fter coronary artery bypass grafting (CABG). We investi-
ated the relationship between the LPS-S447X polymor-
hism and the magnitude of postoperative IL-6 and IL-8
esponse and organ dysfunction in patients undergoing
ABG with CPB.
aterials and Methods
fter obtaining approval to conduct the study from the local ethics
ommittee and written informed consent from each patient, we
nrolled 40 consecutive patients undergoing elective CABG into
he study. Exclusion criteria were unstable angina pectoris,
revious CABG, known cancer, known infection, steroid or
onsteroidal anti-inflammatory therapy, an autoimmune condi-
ion, preoperative intra-aortic balloon pump insertion, emergency
evascularization, long-term dialysis, and hepatic failure. Sixty-six
ealthy control individuals (aged between 35 and 60 years) were
sed to investigate genotype distribution and allele frequencies in
omparison with patients. According to the results of medical
istory, physical examination, and laboratory data, they were
udged healthy.
Medical history, demographic data, and the postoperative
ourse for each patient were collected prospectively. Preoperative
Abbreviation and Acronyms
APACHE Acute Physiology and Chronic Health
Evaluation
CABG  coronary artery bypass grafting
CASUS  cardiac surgery scoring
CK  creatine kinase
CPB  cardiopulmonary bypass
ICU  intensive care unit
IL  interleukin
MODS Multiple Organ Dysfunction Score
LPL  lipoprotein lipase
SIRS  systemic inflammatory response syndrome
TNF  tumor necrosis factorvaluation included routine blood biochemistry, complete blood p
78 The Journal of Thoracic and Cardiovascular Surgery ● Auguount, pulmonary function test, transthoracic echocardiography,
nd coronary angiography. In the postoperative period, patients
ere followed up and treated according to the same institutional
rotocol.
Postoperative daily assessment of organ function in the inten-
ive care unit (ICU) was performed by the cardiac surgery scoring
CASUS) system14 (Appendix 1). In brief, CASUS contains 1
ariables that were graded according to the severity for daily risk
tratification in the ICU. Operative day CASUS score was calcu-
ated when the patient was admitted to the ICU. Then, subsequent
alculations were performed in the morning of each ICU day.
erioperative myocardial infarction was defined by new electro-
ardiographic changes and an increase of 3.5-fold in creatine
inase (CK) isoenzyme MB level. Need for an inotropic agent was
udged by systolic blood pressure lower than 90 mm Hg or more
han 40 mm Hg below usual systolic pressure under appropriate
uid management. Postoperative acute renal dysfunction was de-
ned as a postoperative serum creatinine level greater than 200
mol/L or need for dialysis therapy or hemofiltration before hos-
ital discharge.
All operations were performed by the senior surgeon and two
enior residents. The surgical team and the anesthesiologist who
ere responsible for the postoperative care of the patient were
linded to the presence or absence of LPL S447X stop codon.
nesthesia and Operative Technique
idazolam was used for premedication, and the anesthetic agent
onsisted of a combination of fentanyl, midazolam, and pancuro-
ium. Anesthesia was maintained with midazolam and vecuronium
nfusion and with inhaled sevoflurane. Median sternotomy was
arried out in all patients. Standard aortocaval cannulation was
one to establish CPB. CPB was performed with a roller pump
ystem (Jostra AG, Hirrlingen, Germany) and a hollow-fiber mem-
rane oxygenator (Jostra Quadrox, Hirrlingen, Germany). Also, a
0-m arterial blood filter (Jostra AG) was used in all patients.
ild–to–moderate (28°C–32°C) hypothermia and pulsatile flow of
.2 to 2.4 L/m2 were maintained throughout CPB in all patie
yocardial protection was provided by antegrade tepid blood
ardioplegic solution and topical cooling during aortic crossclamp-
ng. Repeated infusions of 300 mL were given every 20 minutes or
arlier if electrical activity occurred. Rewarming to a normal
asopharyngeal temperature was achieved with a heat-exchange
xygenator and warming blanket. Left internal thoracic artery and
aphenous vein were preferred as bypass conduits in all patients.
he rest of the operation was completed in a standard fashion.
erioperative anticoagulation with heparin was reversed after CPB
ith protamine sulfate. Aprotinin and steroids were not used.
iochemical Measurements
eukocyte count of the blood samples was determined by the use
f the Coulter system (Coulter HMX-AL system hematology an-
lyzer; Beckman Coulter Corporation, Miami, Fla) before induc-
ion, immediately after CPB, and 24 hours after the operation.
actate levels were analyzed (GEM Premier 3000 blood gas/
lectrolyte analyzer model 5700; Instrumentation Laboratory, Lex-
ngton, Mass) from radial artery blood samples taken at preoper-
tively, immediately after CPB, and 6, 12, and 24 hours
ostoperatively. CK (Cobas Integra 700; Roche Diagnostics,
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CDasel, Switzerland) and CK-MB levels (Elecsys 2010; Roche
iagnostics) were measured preoperatively and 6 and 24 hours
fter the operation.
L-6 and IL-8 Levels
evels of IL-6 and IL-8 were measured by enzyme-linked immu-
osorbent assay (Cat No: KHC0061 and KHC0081; Invitrogen, Bio-
ource Division, Carlsbad, Calif) according to the manufacturer’s
ecommendations. The arterial blood samples were collected from
he radial artery catheter into sterile ethylenediaminetetraacetic
cid tubes. After centrifugation, the plasma was collected and then
tored at 20°C until biochemical analysis. Levels of IL-6 and
L-8 were measured at 4 different time points: t1, before induction
f anesthesia; t2, 6 hours after operation; t3, 24 hours after oper-
tion; and t4, 72 hours after operation.
solation of DNA and LPL Genotyping
solation of DNA and LPL genotyping were performed as de-
cribed.15 Whole blood samples for genotyping were drawn -
peratively from both patients and healthy control individuals.
PL gene S447X (refsnp 328) genotype was determined by poly-
erase chain reaction restriction fragment length polymorphism
nalysis using primers 5=-CATCCATTTTCTTCCACAGGG-3=
forward) and 5=-TAGCCCAGAATGCTCACCAGACT-3= (re-
erse) to generate a polymerase chain reaction product of 137 bp,
hich, in the presence of the X447 allele, is digested to 114 and 23
p by HinfI (New England Biolabs, Ipswich, Mass). Fragments
ere separated by electrophoresis on a 6% horizontal polyacryl-
mide gel by microtiter array diagonal gel electrophoresis.16
tatistical Analysis
tatistical analysis was performed with the SPSS for Windows
0.0 version (SPSS, Inc, Chicago, Ill). The 2 test was used to
nalyze relationships between categorical data. Nonparametric
ann–Whitney U test was used to compare IL-6 and IL-8 levels
nd different outcomes between groups. Nonparametric testing
as chosen because the study population was relatively small in
ize and the data did not follow a normal distribution. Association
etween two continuous variables was determined by Spearman
ank correlation. Continuous variables were given as mean 
tandard error of the mean. A 2 test was used to compare the
bserved numbers of each genotype with those expected for a
opulation to establish whether they were in the Hardy–Weinberg
quilibrium. Regression analyses were used to adjust for con-
ounding factors. All tests were 2-sided. All measurements be-
ABLE 1. Genetic profile of control subjects and patients
(/) (/) (/)
ontrols (n  66) 1 (1.5)* 8 (12.1) 57 (86.4)
atients (n  40) 0 7 (17.5) 33 (82.5)
he symbols (/), (/), and (/) stand for homozygote and hetero-
ygote for the absence of the lipoprotein lipase S447X stop codon and
omozygote for the presence of the lipoprotein lipase S447X stop codon,
espectively. *Numbers in parenthesis indicate percentage.ween and within the groups were checked for different time points s
The Journal of Thoracicy repeated-measures analysis of variance with Bonferroni correc-
ions for multiple testing.
esults
enetic characteristics of patients and control subjects were
ummarized in Table 1. Of the 40 patients enrolled i
tudy, 7 (17.5%) patients revealed heterozygote pattern for
he presence of the S447X stop codon (/), which was
ound to be similar to the control population (12.1%). Only
control subject revealed homozygote pattern for the pres-
nce of the LPL S447X stop codon (/). The allele
requency of the LPL S447X allele did not deviate from
ardy–Weinberg expectations (P  .560).
Comparison of the demographics and the preoperative
rofile of the S447X carriers (/) and the noncarriers
/) revealed no difference (Table 2). There was
orrelation between the incidence of hyperlipidemia and the
447X genetic variant. All patients had significant triple-
essel coronary artery disease and normal renal function
reoperatively. Intraoperatively, aortic crossclamp time,
PB time, and the number of performed distal anastomoses
id not differ between the two groups (Table 3). The 
perative data demonstrated that ventilation time was sig-
ificantly longer in the S447X noncarrier group than the
ther group (P .048). The ICU stay was slightly longer in
447X noncarriers than the other group but the difference
as not statistically significant (33.64  3.09 hours vs
0.42  1.08 hours; P  .074). Inotropic drug requirement,
hest tube drainage, perioperative transfusion, and hospital
ABLE 2. Preoperative characteristics of the patients
S447X
noncarriers
(n  33)
S447X
carriers
(n  7) P value
ge 58.04 7.82 58  2.70 .986
ex (male/females) 28/5 5/2 .396
SA (m2) 1.74 0.15 1.80 5.46 .897
moker 17 (55.5) 2 (28.5) .447
M 10 (30.3) 3 (42.8) .519
T 17 (55.5) 3 (42.8) .667
OPD 9 (27.2) 2 (28.5) .760
yperlipidemia 14 (42.4) 3 (42.8) .983
jection fraction (%) 53.16 7.36 61.42 2.82 .013
I history
Recent (3 weeks) 4 (12.1) 1 (14.2) .875
Remote (3 weeks) 8 (24.2) 2 (28.5) .810
reoperative drugs
Beta-blocker 14 (42.4) 3 (42.8) .983
ACE inhibitors 5 (15.1) 1 (14.2) .954
uroSCORE 2.13 0.3 2.35 0.4 .421
M, Diabetes mellitus; HT, hypertension; COPD, chronic obstructive pul-
onary disease; MI, myocardial infarction; ACE, angiotensin-converting
nzyme.tay did not differ between the groups. Leukocyte counts
and Cardiovascular Surgery ● Volume 134, Number 2 479
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A
CDefore induction, immediately after CPB, and 24 hours after
peration were similar between the two groups (P  .663,
722, and .946, respectively).
Postoperative daily assessment of organ dysfunction in
he ICU revealed that S447X noncarriers showed signifi-
antly higher postoperative day 0 (operative day) and day 1
ASUS scores than the carriers (6.85  3.23 vs 4.06 
.38; P .005; and 5  2.38 vs 4.21  0.60; P  .002,
espectively). Owing to the prolonged ICU stay, postoper-
tive day 2 CASUS scores were calculated for only 8
atients in the S447X noncarrier group (5.75  0.81) and
one of the patients in the S447X carrier group. Two
atients in the S447X noncarrier group had acute postoper-
tive renal dysfunction and 1 of them required venovenous
emofiltration or dialysis. There was no perioperative mor-
ality in either group.
The S447X noncarrier group revealed significantly
igher levels of lactate at the postoperative sixth hour than
he other group (4.76  0.23 vs 2.26  0.26 mmol/L; P 
001). Preoperative and postoperative 12- and 24-hour
lasma lactate levels were similar between the two groups
P .744, .066, and .216, respectively) (Figure 1).
Preoperative levels of the IL-6 and IL-8 were detectable
n almost all patients. The peak IL-6 concentration was
etected at the 24th postoperative hour in both groups, and
here were no differences in levels of IL-6 at 4 time points
t1 to t4) between the S447X noncarrier group and the
447X carrier group (t1, 6.48 2.62 pg/mL vs 8.42 1.39
ABLE 3. Relationship between lipoprotein lipase gene po
S447X noncarriers (
ACC time (min) 36.39 1.01
CPB time (min) 69.60 1.59
No. of grafts 3.42 0.12
Perioperative MI 1 (3)
Ventilation time (h) 6.78 0.56
Need for inotropic agents 5 (15.1)
Blood loss 24 hours (mL) 504.54 36.9
Perioperative transfusion
Packaged RBC 5 (15.1)
FFP 2 (6)
TS 1 (3)
ICU stay (h) 33.64 3.09
Postoperative AF 2 (6)
Hospital stay (d) 5.81 0.97
Postoperative ARD 2 (6)
Hemofiltration/hemodialysis 1 (3)/0
CASUS scoring
Operative day 6.85 3.23
Postoperative day 1 5 2.38
CC, Aortic crossclamp; CPB, cardiopulmonary bypass; MI, myocardial
uspension; ICU, intensive care unit; AF, atrial fibrillation; ARD, acute ren
ignificance.g/mL [P  .192]; t2, 37.55  20.69 pg/mL vs 37.04  r
80 The Journal of Thoracic and Cardiovascular Surgery ● Augu.74 pg/mL [P  .776]; t3, 104.93  75.39 pg/mL vs
40.08  54.82 pg/mL [P  .772]; and t4, 60.28  29.7
g/mL vs 93.68  44.14 pg/mL [P  .873]) (Figure 2, A).
he peak IL-8 concentration was detected at the sixth post-
perative hour in both groups (Figure 2, B). There was 
ignificant effect of genotype on IL-8 levels. In the S447X
orphism and perioperative variables
3) S447X carriers (n  7) P value
37 2.70 .681
74.28  4 .318
3.57  0.36 .600
0 .641
4.71  0.28 .048
1 (14.2) .954
521.42  77.04 .747
1 (14.2) .954
0 .504
0 .641
20.42  1.08 .074
0 .504
5.42  0.36 .464
0 .504
0 .641
4.06  0.38 .005
4.21 0.60 .002
tion; RBC, red blood cells; FFP, fresh frozen plasma; TS, thrombocyte
sfunction; CASUS, cardiac surgery scoring. *Boldface P values indicate
igure 1. Comparison of lactate levels. The symbols (/) and
/) stand for homozygote and heterozygote for the absence of
he LPL S447X stop codon, respectively. *P < .05. Error barslym
n  3
5
infarc
al dyepresent the standard error of mean.
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A
CDarrier group, patients had significantly higher IL-8 levels at
oth 6 hours and 24 hours after operation than S447X
oncarriers (98.33  38.41 pg/mL vs 52.85  4.38 pg/mL;
 .005; and 82.82 5.68 pg/mL vs 50.57 8.92 pg/mL;
 .041; respectively). The difference became nonsignif-
cant at 72 hours after operation between the groups
49.18  24.95 pg/mL vs 36.42  8.69 pg/mL; P  .421).
iscussion
ur results showed a highly significant positive correlation
etween postoperative 6- and 24-hour IL-8 levels and the
bsence of the S447X stop codon. Levels of IL-6 did not
eveal a difference according to the genotype. Additionally,
atients carrying S447X genotype revealed lower postoper-
tive organ dysfunction scores and early postoperative lac-
ate levels and had shorter ventilation time than did the
oncarriers. ICU stay was also slightly shorter in S447X
arriers.
The use of CPB is still a prerequisite for many cardiac
urgical procedures. Cardiac surgery with CPB provokes an
cute phase reaction, SIRS, the pathophysiology of which is
uite complex.1-3 Even though the SIRS has been shown
e one of the important determinants of postoperative organ
ysfunction and mortality, the modulators of the tissue
amage are not yet fully clarified. Moreover, it is still
ifficult to estimate the high-risk patient population for
ystemic inflammation and consequent organ dysfunction
fter cardiac operations. Recently, it has been demonstrated
hat the magnitude of the inflammatory cytokine response
nd clinical consequences of CPB-related SIRS are geneti-
ally controlled and vary from patient to patient.4-6 In a
tudy by Guadino and colleagues,4 patients with IL-6-174
/C genotype revealed higher post-CPB IL-6 levels, longer
tays in the hospital and in the ICU, and higher degrees of
enal and pulmonary complications after CABG. Bittar and
olleagues6 demonstrated that patients with AA-308 TNF
enotype showed higher plasma levels of TNF- and less
avorable early outcome than those with AG and GG geno-
ypes after CABG with CPB.
Several polymorphisms at the LPL locus were described,
nd most of them like the Hind III (H allele), the PvuII (P h
The Journal of Thoracicllele), the S291 and the Asp9Asn genetic variants have
een shown to be unfavorably associated with variations in
PL activity, serum lipid concentrations, and the risk and
he progression of coronary artery disease.8,17 LPL S447X
top codon mutation is caused by cytosine to guanine trans-
ersion at nucleotide 1595 in exon 9 that results in the
remature truncation of the LPL enzyme by deleting two
mino acids.8,12 The carrier frequency of this polymorphi
as reported to be 10% to 25% in the general population,
hich was consistent with the frequency in our patient
opulation (17.5%).8 The S447X polymorphism has be
hown to be associated with higher plasma LPL catalytic
ctivity, reduced triglycerides, increased high-density li-
oprotein cytosine and LPL catalytic activity, and a signif-
cantly decreased risk of coronary artery disease.12,13 We
ould not detect a relationship between the S447X stop
odon mutation and hyperlipidemia in this study.
In our patient cohort, patients with LPL S447X stop
odon revealed an exaggerated IL-8 response to CPB
hereas the IL-6 response was not altered according to the
enotype. Increased levels of IL-6 and TNF- have been
ssociated with cardiac dysfunction after CPB.2 However, it
s shown that IL-8 is a potent chemoattractant for neutro-
hils and, therefore, a leading cause for pulmonary leuko-
yte sequestration and associated lung injury after CP3
otani and colleagues18 revealed that IL-8 –mediated ne-
rophil activation is the major cause of CPB-related pulmo-
ary dysfunction, and the number of neutrophils in bron-
hoalveolar lavage after CBP is significantly correlated with
he increases in IL-8 concentrations. Similarly, Grünen-
elder and colleagues7 reported a positive association b-
ween higher postoperative releases of IL-8 and TNF- and
rolonged intubation in patients having TNF- A329G and
polipoprotein E4 polymorphisms. In accordance with re-
ults from the literature, patients with a more pronounced
L-8 response to CPB had longer ventilation times and
igher daily organ dysfunction scores in the present study.
Higher CASUS scores in LPL S447X noncarriers seem
o be related to the increased lactate levels, higher rate of
ulmonary dysfunction, and slightly prolonged ICU stay. It
Figure 2. Mean IL-6 (A) and mean IL-8
levels (B) at 4 different time points. The
symbols (/) and (/) stand for
homozygote and heterozygote for the
absence of the LPL S447X stop codon,
respectively. t1, Before the induction of
anesthesia; t2, 6 hours after operation;
t3, 24 hours after operation; t4, 72 hours
after operation. *P < .05. Error bars
represent the standard error of mean.
IL, Interleukin.as been shown that CASUS has more clinical validity in
and Cardiovascular Surgery ● Volume 134, Number 2 481
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CDritically ill patients in the ICU after cardiac surgery.14 This
xplains why we could not demonstrate a relationship be-
ween scoring and clinical outcome. There were no differ-
nces in the blood leukocyte counts between the groups in
ur study. We think LPL S447X genetic variant exerts a
esistance against the SIRS and some of its consequences,
uch as pulmonary dysfunction, by decreasing the magni-
ude of postoperative IL-8 production after CABG.
Lactate is a widely known marker for the occurrence of
naerobic metabolism resulting from tissue hypoxia or ische-
ia. Excessive cytokine production during SIRS causes an
ncrease in plasma lactate levels.3 Additionally, postopera-
ive lactate level is a good predictor of low cardiac output
nd failure of intra-aortic balloon pumping in cardiac sur-
ery.19,20 It has been demonstrated that IL-8 is one o
ost powerful predictors of lactatemia, severe hypoxemia,
he Acute Physiology and Chronic Health Evaluation
APACHE) II score, and mortality rate in septic sho21
ao and colleagues19 claimed that increased myocardia
actate release during reperfusion reflects a delayed recov-
ry of aerobic myocardial metabolism. In our study, S447X
oncarriers revealed more intense IL-8 and lactate release at
he early postoperative period. However, we could not de-
ect any difference between the two groups in terms of
erioperative CK-MB levels and need for inotropic agents.
he detrimental effects of increased postoperative lactate
nd IL-8 levels on the clinical outcome, particularly on
yocardial metabolism and function, were not obvious, and
his could be related to the well-preserved myocardial func-
ion and energy stores preoperatively in this patient cohort.
he effect of the genotype-related organ dysfunction would
e expected to be more pronounced in patients with more
evere comorbidities.
On the basis of current data about the pathophysiology of
therosclerosis, out of its catalytic activity, LPL exerts some
nflammatory effects in the arterial wall. It enhances human
onocyte adhesion to endothelial cells9 and induces TNF-
ene expression and secretion in macrophages.10 Also, LPL
xerts a synergistic effect on interferon-gamma–induced
itric oxide synthetase expression in macrophages.2,11 Fur-
her molecular studies are essential to clarify the effect of
PL genetic variants on cytokine release after CPB.
Our study has some obvious limitations. First, the num-
er of the patients is small and increasing the number would
ncrease the statistical power of the study. Second, this
tudy demonstrated only a minor difference in terms of
arly morbidity and mortality between the groups. There-
ore, the results of the present study should be considered as
reliminary, and further studies including more high-risk
nd unstable patients are warranted to provide a more rel-
vant clinical conclusion. Third, it would be beneficial to
ncorporate other inflammatory cytokines like IL-1, IL-2,
nd TNF- and anti-inflammatory cytokine IL-10 into the
82 The Journal of Thoracic and Cardiovascular Surgery ● Augutudy. Fourth, CASUS was preferred for the assessment of
aily organ dysfunction. More clinical studies are warranted
o test its validity and effectiveness in cardiac surgical
atients. However, standard ICU scoring systems such as
PACHE II and Multiple Organ Dysfunction Score
MODS) were originally designed to estimate the risk for
ritically ill patients in the ICU, but not specifically for
ardiac surgical patients. These scoring systems lack some
mportant postoperative parameters such as lactate and intra-
ortic balloon pump usage, which were shown to be impor-
ant determinants of postoperative morbidity and mortality
n cardiac surgical patients. Last, some claimed that me-
hanical ventilation is an important contributing factor to
he SIRS in cardiac surgery.22 In our study, prolonge
entilation in the S447X noncarrier group might have ex-
ggerated the IL-8 release by attracting additional neutro-
hils and caused a vicious cycle. Therefore, further studies
re warranted.
In conclusion, our results show that LPL S447X genetic
ariant exerts, at least partially, a resistance to SIRS by
ecreasing post-CPB levels of IL-8 after CABG. Preopera-
ive LPL S447X genotyping may be beneficial in detecting
atients with a genetically determined risk for an exagger-
ted cytokine response, especially IL-8, and postoperative
rgan dysfunction after CPB. Alternative treatment strate-
ies such as off-pump CABG and more aggressive ICU
anagement may help to improve the outcome in these
t-risk patients. Moreover, insight into the mechanisms un-
erlying the differences in cytokine release among LPL
olymorphisms may eventually facilitate the understanding
f the pathophysiology of the SIRS after CPB.
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2 points 3 points 4 points
151-250 75-150 75
2.3-4.0 4.1-5.5 5.5
3.6-7.0 7.1-14.0 14.0
15.1-20.0 20.1-30.0 30.0
actic acid (mmol/L) 2.1 2.1-4.0 4.1-8.0 8.1-12.0 12.0
latelets (mL  103) 120 81-120 51-80 21-50 21
eurologic state Normal status Not scored Confused conversation Sedated Diffuse neuropathy
ntra-aortic balloon pump No Not scored Not scored Not scored Yes
entricular assist device No Not scored Not scored Not scored Yes
VVH/dialysis No Not scored Not scored Not scored Yes
ncreasing abnormality was graded on a scale from 0 to 4 score points: a score of 0 representing normal or minimally deranged function, a score of 4
orrelating with a markedly deranged function. PO /FIO , The ratio of arterial PO (mm Hg) and fractional inspired oxygen concentration; PAR,2
P, mean arterial pressure; CVVH, continuous venovenous hemofiltration.
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